[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366947-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366947-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","human-papillomavirus-type-16-and-18-in-urothelial-bladder-neoplasms-detection-quantification-and-comparison-with-nonneoplastic-samples","Human papillomavirus type 16 and 18 in urothelial bladder neoplasms - detection, quantification, and comparison with nonneoplastic samples","","Bladder cancer represents a prevalent urothelial malignancy, with growing interest in whether Human Papillomavirus (HPV) contributes to its development. This retrospective cross-sectional study assesses HPV types 16 and 18 in tissue from urothelial bladder carcinoma patients and compares results with non-neoplastic controls. Real-time PCR is used to detect and quantify viral presence and viral load. Higher high-risk HPV prevalence is observed in cancer cases, and HPV-16 and HPV-18 viral loads increase in the cancer group, supporting a potential role for HPV in progression and persistent infection.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/human-papillomavirus-type-16-and-18-in-urothelial-bladder-neoplasms-detection-quantification-and-comparison-with-nonneoplastic-samples/366947/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/human-papillomavirus-type-16-and-18-in-urothelial-bladder-neoplasms-detection-quantification-and-comparison-with-nonneoplastic-samples/366947.png","ImageObject",300,407,{"name":42,"@type":43},"CatatanPagi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the study investigate about HPV in bladder cancer?","Question",{"text":63,"@type":64},"The study examines the prevalence and viral load of HPV types 16 and 18 in urothelial bladder neoplasms and compares them with non-neoplastic samples.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were HPV types 16 and 18 detected and quantified?",{"text":68,"@type":64},"DNA from tissue samples was extracted and analyzed using real-time PCR to detect and quantify HPV-16 and HPV-18.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the main findings regarding HPV prevalence and viral load?",{"text":72,"@type":64},"High-risk HPV types 16 and 18 were more prevalent in bladder cancer patients than controls, though the difference in prevalence was not statistically significant. Viral loads for HPV-16 and HPV-18 were significantly higher in the cancer group.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366947,1790485801,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Yazdani etal. Infectious Agents and Cancer (2026) 21:9 Infectious Agents and Cancer  \n[https://doi.org/10.1186/s13027-025-00725-4](https://doi.org/10.1186/s13027-025-00725-4)  \nRESEARCH Open Access  \nHuman papillomavirus type 16 and 18 in urothelial bladder neoplasms: detection, quantification, and comparison with nonneoplastic samples  \nArshia Yazdani 1, Ghodsieh Kamrani2, Arefeh Ebrahimian Shiadeh3, Emadoddin Moudi4, Zeinab Vosough2, Hoda Shirafkan5, Farzin Sadeghi6* and Akramossadat Hosseini2*  \nAbstract  \nBackground Bladder cancer is a prevalent urothelial cancer, and recent studies have focused on the potential role of Human Papillomavirus (HPV) in its development. This study investigates the prevalence and viral load of HPV types 16 and 18 in bladder urothelial neoplasms and compares these findings with non-neoplastic samples.  \nMethods A retrospective cross-sectional study was conducted using tissue samples from patients with urothelial bladder carcinoma (UBC) and a non-neoplastic control group. DNA was extracted and analyzed using real-time PCR to detect and quantify HPV types 16 and 18.  \nResults Although the prevalence of high-risk HPV types (16 and 18) was higher in bladder cancer patients compared to controls, the difference was not statistically significant. However, HPV-16 viral load was significantly higher inpatients (P \u003C 0. 001), and HPV-18 viral load was also significantly elevated (P = 0 . 004) . Both HPV-16 and HPV-18 viral loads were generally higher in bladder cancer patients compared to healthy individuals.  \nConclusion This study demonstrated an increased prevalence of high-risk HPV types in bladder urothelial neoplasms, with elevated viral loads for HPV-16 and HPV-18 in the cancer group. While these differences were not statistically significant, the increased viral load suggests that HPV may play a role in bladder cancer progression, particularly in cases of persistent infection. These findings highlight the importance of strengthening HPV vaccination programs and further investigation into the long-term effects of HPV on bladder cancer.  \nKeywords Bladder cancer, Human papillomavirus, Urothelial neoplasm  \n*Correspondence:  \nFarzin Sadeghi[sadeghifarzin6@gmail.com](sadeghifarzin6@gmail.com)[ ](sadeghifarzin6@gmail.com)Akramossadat Hosseini [Dr_Hosseini_2006@yahoo.com](Dr_Hosseini_2006@yahoo.com)  \n1Student Research Committee, Babol University of Medical Sciences, Babol, Iran  \n2Department of Pathology, School of Medicine, Babol University of Medical Sciences, Babol, Iran  \n3Department of Medical Microbiology, Faculty of Medicine, Golestan University of Medical Science, Gorgan, Iran  \n4Clinical Research Development Center, Shahid Beheshti Hospital, Babol University of Medical Sciences, Babol, Iran  \n5Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Science, Babol, Iran  \n6Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/.  \nYazdani et al. Infectious Agents and Cancer (2026) 21:9  \nIntrod","cbCairbhwDMzxQBR","https://ap.wps.com/l/cbCairbhwDMzxQBR","pdf",1267247,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What does the study investigate about HPV in bladder cancer?\",\"answer\":\"The study examines the prevalence and viral load of HPV types 16 and 18 in urothelial bladder neoplasms and compares them with non-neoplastic samples.\"},{\"question\":\"How were HPV types 16 and 18 detected and quantified?\",\"answer\":\"DNA from tissue samples was extracted and analyzed using real-time PCR to detect and quantify HPV-16 and HPV-18.\"},{\"question\":\"What were the main findings regarding HPV prevalence and viral load?\",\"answer\":\"High-risk HPV types 16 and 18 were more prevalent in bladder cancer patients than controls, though the difference in prevalence was not statistically significant. Viral loads for HPV-16 and HPV-18 were significantly higher in the cancer group.\"}]","Human papillomavirus type 16 and 18 in urothelial bladder neoplasms - detection, quantification, and comparison with nonneoplastic samples | PDF",1790168320,18,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75cc68f0cd24f9692f3a1f3e41dd73cf.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f2008bc07140c9c67a6bd1e34509969.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7732814616e92329239a56ef2f8c8f6.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76cb93c7c56c275df5bc17cddd912449.webp",980,1306]